Haemonetics Corp. buy BTIG Research
Start price
06.11.25
/
50%
€57.50
Target price
06.11.26
€76.46
Performance (%)
19.13%
Price
22.12.25
€68.50
Summary
This prediction is currently active. The prediction currently has a performance of 19.13%. This prediction currently runs until 06.11.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 0.000% | 0.000% |
| iShares Core DAX® | 0.224% | 2.457% |
| iShares Nasdaq 100 | 0.371% | -0.320% |
| iShares Nikkei 225® | 0.972% | -0.829% |
| iShares S&P 500 | 0.417% | -0.157% |
Comments by BTIG_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (NYSE:HAE) had its price target raised by analysts at BTIG Research from $85.00 to $88.00. They now have a "buy" rating on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by BTIG_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€66.50
10.09.24
10.09.24
€101.52
10.09.25
10.09.25
-32.03%
11.09.25
11.09.25
